Compendium of Cancer Genome Aberrations

Changes

HAEM5:Volunteer Assignments and Opportunities (view source)

Revision as of 14:04, 21 March 2024

666 bytes added ,  21 March
no edit summary
Line 2,085: Line 2,085:  
|
 
|
 
|
 
|
 +
|-
 +
|Disease (5th Edition)
 +
|Page Type
 +
|Author (5th Edition) (Note: please indicate trainees in parenthesis)
 +
|Date Assigned to Author (5th Edition)
 +
|Target Completion Date (5th Edition)
 +
|Content Status (5th Edition) (Pending or Complete)
 +
|Date Completed by Author (5th Edition)
 +
|Associate Editor
 +
|Date of Last Editor Review (5th Edition)
 +
|Notes (5th Edition)
 +
|Correlated Prior Disease Name (4th Edition)
 +
|Correlated Prior Author (4th Edition)
 +
|Prior Content Status (4th Edition) (Pending or Complete)
 +
|Prior Date of Last Editor Review (4th Edition)
 +
|Prior Notes (4th Edition)
 
|-
 
|-
 
|CHAPTER 5 (T-CELL AND NK-CELL LYMPHOID PROLIFERATIONS AND LYMPHOMAS)
 
|CHAPTER 5 (T-CELL AND NK-CELL LYMPHOID PROLIFERATIONS AND LYMPHOMAS)
Line 2,179: Line 2,195:  
|[[HAEM5:T-large granular lymphocytic leukaemia|T-large granular lymphocytic leukaemia]]||Disease||Michelle Don, MD, MS
 
|[[HAEM5:T-large granular lymphocytic leukaemia|T-large granular lymphocytic leukaemia]]||Disease||Michelle Don, MD, MS
 
|3/17/24
 
|3/17/24
−
| ||Pending
+
|6/30/24
 +
|Pending
 
| ||SK|| ||
 
| ||SK|| ||
 
|T-cell Large Granular Lymphocytic Leukemia
 
|T-cell Large Granular Lymphocytic Leukemia
Line 2,189: Line 2,206:  
|[[HAEM5:NK-large granular lymphocytic leukaemia|NK-large granular lymphocytic leukaemia]]||Disease||Michelle Don, MD, MS
 
|[[HAEM5:NK-large granular lymphocytic leukaemia|NK-large granular lymphocytic leukaemia]]||Disease||Michelle Don, MD, MS
 
|3/17/24
 
|3/17/24
−
| ||Pending
+
|6/30/24
 +
|Pending
 
| ||SK|| ||
 
| ||SK|| ||
 
|Chronic Lymphoproliferative Disorder of NK Cells
 
|Chronic Lymphoproliferative Disorder of NK Cells
Line 2,307: Line 2,325:  
|NEW (No Prior)
 
|NEW (No Prior)
 
|-
 
|-
−
|[[HAEM5:Enteropathy-associated T-cell lymphoma|Enteropathy-associated T-cell lymphoma]]||Disease||PENDING
+
|[[HAEM5:Enteropathy-associated T-cell lymphoma|Enteropathy-associated T-cell lymphoma]]||Disease||Monica Fnu (trainee), Andrew Siref, MD
−
| || || || ||SK|| ||
+
|3/20/24
 +
| || || ||SK|| ||
 
|Enteropathy-Associated T-cell Lymphoma
 
|Enteropathy-Associated T-cell Lymphoma
 
|*Derick Okwan-Duodu, MD, PhD *Sumire Kitahara, MD
 
|*Derick Okwan-Duodu, MD, PhD *Sumire Kitahara, MD
Line 2,315: Line 2,334:  
|
 
|
 
|-
 
|-
−
|[[HAEM5:Monomorphic epitheliotropic intestinal T-cell lymphoma|Monomorphic epitheliotropic intestinal T-cell lymphoma]]||Disease||PENDING
+
|[[HAEM5:Monomorphic epitheliotropic intestinal T-cell lymphoma|Monomorphic epitheliotropic intestinal T-cell lymphoma]]||Disease||Monica Fnu (trainee), Andrew Siref, MD
−
| || || || ||SK|| ||
+
|3/20/24
 +
| || || ||SK|| ||
 
|Monomorphic Epitheliotropic Intestinal T-cell Lymphoma
 
|Monomorphic Epitheliotropic Intestinal T-cell Lymphoma
 
|Derick Okwan-Duodu MD, PhD; Sumire Kitahara, MD
 
|Derick Okwan-Duodu MD, PhD; Sumire Kitahara, MD
Line 2,333: Line 2,353:  
|[[HAEM5:Hepatosplenic T-cell lymphoma|Hepatosplenic T-cell lymphoma]]||Disease||Michelle Don, MD, MS
 
|[[HAEM5:Hepatosplenic T-cell lymphoma|Hepatosplenic T-cell lymphoma]]||Disease||Michelle Don, MD, MS
 
|3/19/24
 
|3/19/24
−
| ||Pending
+
|6/30/24
 +
|Pending
 
| ||SK|| ||
 
| ||SK|| ||
 
|Hepatosplenic T-cell Lymphoma
 
|Hepatosplenic T-cell Lymphoma
Retrieved from "https://ccga.io/index.php/Special:MobileDiff/14387"